6.520USD+24.67%Mkt Cap: 188.56M USDP/E: —Last update: 2026-06-01
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic thro…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap188.56M USD
Enterprise Value149.69M USD
Revenue (TTM)—
Gross Profit-974.60K USD
Net Income (TTM)-3.84M USD
Revenue/Share—
Last Price6.520 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-34.67
PEG—
EV/EBITDA-19.59
EV/Revenue—
P/S—
P/B288.89
EPS (TTM)-0.13
EPS (Forward)-0.15
52W Range
2.57017% of range26.50
52W High26.50 USD
52W Low2.570 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-129.17%
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.36M USD
CapEx (TTM)99.47K USD
FCF Margin—
FCF Yield—
Net Debt-5.21M USD
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity-0.68
Current Ratio2.23
Quick Ratio2.19
Book Value/Sh0.0180 USD
Cash/Share0.3770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.29.79M
Float11.13M
Insiders63.74%
Institutions1.74%
Short Interest
Short Ratio2.8d
Short % Out.0.22%
Shares Short51.42K
Short (prev mo.)60.22K
Technical
SMA 503.808 (+71.2%)
SMA 2003.999 (+63.0%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)39.95K
Avg Vol (10d)63.91K
Technical Indicators
RSI (14)71.7
MACD0.4474
MACD Signal0.3531
MACD Hist.+0.0943
BB Upper5.671 USD
BB Middle4.398 USD
BB Lower3.126 USD
BB Width57.86%
ATR (14)0.3709 USD
Vol Ratio (20d)3.98x